MedTrace Logo

APPRAISE 2.0: Live Trial of the APPRAISE Trauma Decision Support System

NCT06121661 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-05-08

No results posted yet for this study

Summary

This is a pilot evaluation of the APPRAISE trauma decision-support software system ("the System"). The specific objections are as follows:

1. Evaluate the robustness of the System (i.e., whether the software performs in real-time in accordance with a priori technical specifications during real-time clinical use);
2. Evaluate whether the real-time display of the System causes distraction or confusion to clinicians treating the trauma patient such that its risks exceed its benefits;
3. Collect pilot data to allow for a statistical power analysis to design a future clinical trial evaluating efficacy.

Conditions

  • Wounds and Injuries

Interventions

DEVICE

APPRAISE Trauma Clinical Decision Support System

Real-time bedside decision-support system for trauma patient management

Sponsors & Collaborators

  • Andrew Tomas Reisner

    lead OTHER

Principal Investigators

  • Andrew Reisner, MD · Massachusetts General Hospital

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-21
Primary Completion
2027-12-14
Completion
2028-12-14
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06121661 on ClinicalTrials.gov